Crossmark

Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage

Crossref DOI link: https://doi.org/10.1007/s12028-021-01369-z

Published Online: 2021-10-27

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Mengxuan

Shin, Hye Jung

Metcalf-Doetsch, William

Luo, Yuan

Lindholm, Paul F.

Kwaan, Hau

Naidech, Andrew M. https://orcid.org/0000-0003-1065-5417
Funding

Funding for this research was provided by:

National Institutes of Health (R01 NS110779, U01 NS110772)

National Center for Advancing Translational Sciences (UL1TR001422)
License Information

Text and Data Mining valid from 2021-10-27

Version of Record valid from 2021-10-27
More Information

Article History

Received: 22 April 2021

Accepted: 27 September 2021

First Online: 27 October 2021

Conflict of interest

: The authors declare that they have no conflicts of interest. Dr. Naidech reports grants from the National Institutes of Health during the conduct of the study.

: Approval for this study was granted by an institutional ethical standards committee on human experimentation.

Document is current

Any future updates will be listed below